The group’s principal activities include developing, manufacturing, marketing and servicing the mobile electron beam system designed for intraoperative radiotherapy treatment of cancer, coronary, vascular restenosis and other medical applications. In March 2005, the group acquired Intraop Medical, Inc. The group operates from the United States and Europe. The revenue of the group in the year 2006, were $5,982,954.